Olympia Pharmacy Recalls Methylcobalamin and Folic Acid Injection Due to Sterility Concerns
Olympia Pharmacy is recalling Methylcobalamin and Folic Acid Injection due to FDA inspection findings regarding quality control and sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant risks such as sterility assurance issues in injectable drugs are categorized as Severe.
Plain-English summary
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection. The recall was initiated following FDA inspection findings that raised concerns regarding quality control processes and the assurance of sterility for the product.
The affected product is identified by code L3326 with an expiration date of 6/30/13. The recall is classified as Class II by the FDA. Distribution was nationwide and in Puerto Rico.
Consumers should stop using the recalled product and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- L3326 Exp 6/30/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 105 products in this recall →Related recalls
Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy
See all →- SevereOlympia Pharmacy Recalls Diclazuril Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- HighOlympia Pharmacy Recalls Metabolase Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Betamethasone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls HACC 270.1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
Same hazard · sterility
See all →- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighInjectable Folic Acid and Hydroxocobalamin Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-06-01
- HighMethylcobalamin Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- SevereFDA Recalls Methylcobalamin and Folic Acid Injectables Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- HighCyanocobalamin Injectable Vials Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- SevereMethylcobalamin Injection Recalled for Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereFallon Wellness Pharmacy Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20